The Ultrahuman Ring Pro builds on the Ultrahuman Ring Air's features with several key improvements, including an impressive battery life of up to 15 days, which is more than twice as long as the Air.
EchoPrime, a video-based vision-language model, analyses echocardiogram footage and generates a written report of cardiac form and function. Its findings were published in Nature (volume 650, pages 970-977) in February 2026, under the title 'Comprehensive echocardiogram evaluation with view primed vision language AI.'
The glasses, developed over ten years, can guide people living with early-stage dementia through daily activities by identifying everyday objects and providing audio commentary and putting up visual prompts.
Since 1990, the incidence of hypertension has increased globally, with up to one in three adults worldwide affected by it. Most of those people have no idea they have it. If people could diagnose and monitor hypertension at home, the World Health Organization estimates that up to 76 million lives could be saved with easy fixes, like stopping smoking or adjusting diet.
The Ultrahuman Ring Pro advertises up to 15 days of battery life. For comparison, the Ultrahuman Ring Air lasts 4-6 days on a charge according to official numbers. That's a massive upgrade but isn't the end of it either. The new ring comes with a new Pro Charger, which extends the ring's endurance up to 45 days.
Meta is building a smartwatch, and it wants to know your heart rate, your sleep patterns, your activity levels, and whatever else it can pull from a sensor pressed against your skin all day. The device is codenamed Malibu 2, it's targeting a 2026 launch, and by most accounts it sounds like a perfectly competent health wearable. The problem isn't the hardware. The problem is the company attached to it.
We use the IMU sensors to detect which exercise the user is performing and identify the period engaging in concentric, eccentric, or isometric hold. These are the three main types of lifting exercises; you might know them as contracting, lengthening, or static exercises. The Fort uses the wrist as a proxy for bar velocity, and the company is seeking FDA clearance and will also be pursuing large, third-party studies from independent labs.
Artificial intelligence (AI) machine learning is making a difference in assistive technology to help restore movement for the paralyzed. A new study in the American Institute of Physics journal APL Bioengineering shows how AI has the potential to restore lower-limb functions in those with severe spinal cord injuries (SCIs) by identifying patterns in brain signals captured noninvasively via electroencephalography (EEG).
Public health consultant Dr Ross Keat said supporting people earlier to make small preventative changes would make "a big difference later on". Some 3,500 people in the north of the island within that age bracket are eligible for the checks. The checks will be carried out by two pre-existing nurses that support GP staff and would not replace GP appointments, Keat explained, adding that the cost would be minimal and absorbed by Ramsey Group Practice.
Petal is a bra insert that uses bio-impedance sensors and electrical measurements to monitor blood flow near the heart. Because wearers position the insert right next to the heart, the device can capture more accurate readings than your typical smartwatch, Petal says. The device comes in one size and fits snug against each breast. It's made with biocompatible materials, including a soft European fabric and a polyurethane-coated interior.
As OpenAI launches ChatGPT Health, allowing users to connect medical records and wellness apps for AI-driven health guidance, a new survey from Drip Hydration confirms Americans are increasingly turning to AI for medical advice. The nationwide survey explores the motivations, demographics, and regional trends behind this growing phenomenon. The data reveals where and why people are choosing AI alongside traditional medical channels in their healthcare journey.
He has been living with atrial fibrillation (AF), a common heart rhythm problem, affecting 1.4m people in the UK, that can cause your heart to beat irregularly and often too fast. "It's very debilitating. On my worst day I feel very tired, my heart rate increases rapidly - I could walk for 2 or 3 miles and be okay, I could walk for 100 yards and it would hit me."
When people breathe, speak, sing or clear their throats, their bodies are in constant motion. Air flowing through the lungs, the oscillation of vocal folds in the throat and the rhythmic expansion of the chest all produce tiny vibrations that carry valuable information about physiology and health. However, constructing a device that can capture all of these physiological signals has remained a challenge.
The FlowPad looks like your run-of-the-mill menstrual pad but is built with a microfluidic diagnostic layer underneath that directs menstrual blood into biomarker zones for testing fertility, ovarian health, and perimenopausal hormones. The results of the test show up in Vivoo's app after a user scans the pad's results through their phone camera or enters them manually. The ethos behind FlowPad and Vivoo's smart toilet is simple.
After losing both of his parents to cancer, Tom set out to challenge a healthcare system that often waits for symptoms instead of identifying risk early. What began in Deerfield Beach, Florida, has grown into a multi-location preventative imaging company serving communities across the state. Life Imaging Fla focuses on preventative heart and full-body screenings. These services give people access to advanced imaging that is typically only approved once symptoms appear. The goal is straightforward: identify disease earlier, when people still have time, options, and control.
By attaching near the ear, the device targets the auricular branches of the trigeminal and vagus nerves to regulate menstrual cycle symptoms and help the body return to a rested state. These nerves play an important role throughout the menstrual cycle and release estrogen and progesterone, two essential sex hormones. They also target muscle contraction, blood flow, digestion, and more, a few body functions that change during a period, which explains the increase in cramps and tightening of blood vessels.
My dad was in the emergency room, short of breath, chest tight, upper back aching. He looked pale and confused. An ultrasound showed excess fluid between his lung and chest wall. "We'll drain it," a resident said, as if he were unclogging a sink. For the next five days, thick, red-tinged fluid filled a plastic container beside my dad's hospital bed. Doctors sent his cells for "staining," a way to identify cancer. But no one used that word.
Last Wednesday morning, I woke up and did what I normally do when I open my eyes. I grabbed my phone and checked my Oura app to see how I slept. This morning, however, Oura's home page looked a bit different. Unlike the sleep and readiness scores I usually see on the home page, a new message appeared on top. While no biomarker deviated strongly from my baseline, Oura's Symptom Radar feature warned me that my biometrics indicated "major signs of strain." It encouraged me to take it easy -- a tall task given that I was headed into the office for the workday.